Clinical trials: Pharmacist
Diabetes Mellitus, Type 2
Pharmacist-led Intervention in Treatment Non-adherence in Southwestern Nigeria
Summary of the Research Medication non-adherence has a huge economic impact on the patient and the society at large. World Health Organization (WHO) has suggested that noncompliance with medication is a common problem which often…
- Trial name
- NCT04712916
- Testing
- Health education
- Where
- Nigeria
- Volunteers
- 401 people, healthy volunteers welcome
- Sponsor
- University of Ibadan
Neoplasm
Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation
The purpose of this observational study is to evaluate the benefits of a pharmacist integration in an oncology ambulatory center, to prevent drug related problems (in particular drug drug interactions) at antitumor treatment…
- Trial name
- CHOPIN (NCT04142567)
- Where
- France
- Volunteers
- 440 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
HIV I Infection
The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV
The purpose of The EXPAND study is to develop and pilot a pharmacist led model of medication delivery. Following a co-design phase, patients may receive injections at satellite pharmacies by a licensed pharmacist.
- Trial name
- EXPAND (NCT06635421)
- Testing
- Model of care delivery for long-acting injectable ART
- Volunteers
- 164 people
- Sponsor
- MetroHealth Medical Center
Contraception, Pharmaceutical Services
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1.
- Conditions
- Contraception, Pharmaceutical Services, Access and Linkage to Healthcare, Technology Use
- Trial name
- HAPPI (NCT06823037)
- Testing
- HAPPI software
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- EMPOWERX INC
Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia
Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
The objective of this study is to improve medication, symptom, and disease management of patients with hematological malignancies and multiple chronic conditions (2 or more conditions in addition to cancer) through care…
- Conditions
- Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions
- Trial name
- NCT04595851
- Testing
- Patient Reported Outcome Measure (PROM), Comprehensive Medication Review (CMR), Communications between oncology and primary care pharmacists
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- University of Michigan Rogel Cancer Center
Heart Failure, Patient Readmission
Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services
Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.
- Trial name
- NCT02752997
- Testing
- Pharmacist discharge medication services
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
Intensive Care Admission
The Impact of Clinical Pharmacists Role in Transition of Care From Other Departments to Critical Care Units in Alexandria Main University Hospital.
Transition of care between hospital departments is an important step in patient care. Every patient may need to be transmitted either for case deterioration, improvement or interventions purposes.
- Trial name
- NCT06903572
- Testing
- the clinical pharmacists interventions about medication related information during transition of care
- Where
- Egypt
- Volunteers
- 126 people
- Sponsor
- Alexandria University
Diabetic Peripheral Neuropathy
The Role of a Clinical Pharmacist in Lifestyle Modification in Type 2 Diabetic Patients With Peripheral Neuropathy
The aims of this study are to determine the prevalence of diabetic peripheral neuropathy among the diabetic patients, to determine the association between the clinical profiles of the diabetic patients (diabetes type, diabetes…
- Trial name
- NCT03356041
- Testing
- Diabetic patients with neuropathy
- Where
- Iraq
- Volunteers
- 200 people
- Sponsor
- Hawler Medical University
Patient Admission, Patient Discharge
Combined Social Worker and Pharmacist Transitional Care Program
In an effort to improve care coordination and reduce hospital readmissions, Rush University Medical Center developed the Combined Social Worker and Pharmacist Program, which targets both the psychosocial and clinical risk factors…
- Trial name
- NCT01503554
- Testing
- Combined Social Worker and Pharmacist Program, No Intervention: Usual Care
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Rush University Medical Center
HIV Infections
A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV
An estimated 21% of Canadians with HIV are unaware of their infection. There is a need to improve access to HIV testing to detect infections earlier so individuals can access care early and take steps to prevent transmission to…
- Trial name
- APPROACH (NCT03210701)
- Testing
- A HIV POCT program adapted for & provided by community pharmacists
- Where
- Canada
- Volunteers
- 123 people, healthy volunteers welcome
- Sponsor
- Memorial University of Newfoundland
Hypertension, Diabete Type 2
Pharmacists Interventions on Patients Diabetic, and Obese Patients in the UAE: Randomized Controlled Trials.
Hypertension, diabetes, and obesity are considered major risk factors for cardiovascular diseases and premature mortality worldwide. Furthermore, they have severe consequences on quality of life among patients.
- Conditions
- Hypertension, Diabete Type 2, Obesity, Pharmacist-Patient Relations
- Trial name
- NCT05488002
- Testing
- Pharmaceutical intervention
- Volunteers
- 720 people, healthy volunteers welcome
- Sponsor
- University of Sharjah
Self-medication for Pain, Limits on Advice From Community Pharmacists and Referral to a Primary Care Practitioner
Impact of Pharmaceutical Intervention in Self-Medication: Focus on Pain Management in Pharmacies
Self-medication is an increasingly common practice that carries risks. When a patient requests self-medication, the community pharmacist intervenes in the identification, prevention and resolution of medication-related problems.
- Trial name
- AUTOMED'IP-DOL (NCT07867301)
- Testing
- Care monitoring by the pharmacist's telephone call
- Volunteers
- 376 people
- Sponsor
- University Hospital, Clermont-Ferrand
Diabetes Mellitus, Type 2, Diabetic Nephropathies
Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations
This retrospective study evaluates whether providing clinicians with artificial intelligence (AI)-based kidney function results from a breath ammonia test can improve the quality of medication recommendations made by clinical…
- Trial name
- NCT07888855
- Where
- China
- Volunteers
- 380 people
- Sponsor
- Shanghai Pudong Hospital
Diabetes Mellitus, Type 2
A Community Pharmacy-based Program to Improve Management of Diabetes
In this study the investigators aim to evaluate the impact of a community pharmacy-based program to educate type 2 diabetic patients about medications, life style and self-care.
- Trial name
- NCT01525992
- Testing
- Community pharmacist-led diabetes education program, Usual care
- Where
- Iran
- Volunteers
- 101 people
- Sponsor
- Tehran University of Medical Sciences
Chemotherapy Side Effects, Social Media
The Impact of Social Media-delivered Chemotherapy Side Effects Education for Breast Cancer Patients Receiving Chemotherapy
The goal of this clinical trial is to learn if a standardized pharmacists-provided education module by social media can improve patients' knowledge of chemotherapy-related side effects.
- Conditions
- Chemotherapy Side Effects, Social Media, Education of Patients
- Trial name
- NCT06791603
- Testing
- Standardized chemotherapy education + video
- Where
- Taiwan
- Volunteers
- 100 people
- Sponsor
- Taipei Medical University Shuang Ho Hospital
Osteoporosis, Osteopenia
Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors
The study seeks to determine the impact of assessing risk for osteoporosis in women on patient and physician behaviors through a pharmacist directed osteoporosis screening program.
- Trial name
- NCT01572766
- Testing
- FRAX Assessment Tool
- Where
- United States
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Duquesne University
Prediabetes
Pharmacist-Led Continuous Glucose Monitoring for Prediabetes
The goal of this observational study is to determine if a pharmacist-led program involving continuous glucose monitoring (CGM) improves glucose control and health behavior in people with prediabetes.
- Trial name
- NCT07529366
- Testing
- Dexcom Stelo CGM
- Where
- 2 sites in United States
- Volunteers
- 40 people
- Sponsor
- University of South Florida
COPD, Asthma
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED)…
- Trial name
- PILLAR (NCT03927820)
- Testing
- Benefits investigation
- Where
- United States
- Volunteers
- 914 people
- Sponsor
- Vanderbilt University Medical Center
Geriatric
Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program
To evaluate the impact of clinical pharmacist-led appropriate acid suppression therapy stewardship program in hospitalized older patients.
- Trial name
- NCT05113667
- Testing
- Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program
- Where
- Turkey (Türkiye)
- Volunteers
- 250 people
- Sponsor
- Marmara University
Infectious Disease, Pneumonia, Bacterial
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination.
- Conditions
- Infectious Disease, Pneumonia, Bacterial, Influenza, Zoster; Herpes
- Trial name
- VEPSC (NCT03239665)
- Testing
- Pharmacist-led Intervention (PHARM), Peer-led Intervention (PEER)
- Where
- United States
- Volunteers
- 335 people, healthy volunteers welcome
- Sponsor
- Rutgers, The State University of New Jersey